News Search Results
Sep 18, 2025, 16:00 ET Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection
2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce its ongoing collaboration with Freedom Farm, a sanctuary dedicated to rescuing animals that were expelled from
More news about: Innocan Pharma Corporation
Sep 18, 2025, 16:00 ET Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce its ongoing collaboration with Freedom Farm, a sanctuary dedicated to rescuing animals that were expelled from
More news about: Innocan Pharma Corporation
Sep 18, 2025, 10:14 ET Global Autonomous Vehicle Market Size & Share to Surpass $658.1 Billion by 2035, Growing at a CAGR 22.19% | Driving the Future of Mobility, Transportation, and Smart Cities
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Sep 18, 2025, 10:05 ET nuBioAge's Clinical Longevity Summit Gathers World-Leading Physicians in West Palm Beach to Deliver the First Comprehensive Roadmap for Post-COVID Treatment
symptoms. She brought special guest researcher and chemist, Dr. Simone Cristoni, from ISB: Ion Source and BioTechnology R&D Labs, to introduce breakthrough diagnostics capable of differentiating between vaccine-derived and wild-type spike proteins, paving the
More news about: NUBIOAGE LLC
Sep 18, 2025, 10:01 ET Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Surges to USD 60.3 Billion by 2033, Propelled by 7.3% CAGR - Verified Market Reports®
Assurance ServicesPost-Manufacturing Support ServicesBy End-user Industries PharmaceuticalsBiotechnologyHealthcareCosmetics and Personal CareFood and BeverageBy Scale of Production Small
More news about: Verified Market Reports
Sep 18, 2025, 10:01 ET Cloud Object Storage Market Driven by Rising Data Growth, Scalability Needs, and Enterprise Cloud Adoption Across Key Industry Verticals - Market Research Intellect
Thermostatic Baths Market is categorized based on Application (Pharmaceutical Laboratories, Chemical Research, Biotechnology, Food & Beverage Testing, Environmental Testing, Academic & Educational Labs, Clinical Diagnostics) and Type (Heated Circulating Baths,
More news about: Market Research Intellect
Sep 18, 2025, 10:00 ET Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test
Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: Roche Diagnostics
Sep 18, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY
[Click here for information about joining the class action] Unicycive is a clinical-stage biotechnology company that identifies, develops, and commercializes therapies to address unmet medical needs in the U.S. The Company is developing, among other
More news about: Pomerantz LLP
Sep 18, 2025, 09:20 ET AIChE Awards Its 2025 Langer Prize to Mark Blenner of the University of Delaware
regulation to catch up; therefore, innovations must deliver significant value to early adopters and have the potential to scale to larger markets. Biotechnology, including microbes and enzymes, has the potential to efficiently process mixed, uncleaned plastic waste and be deployed in decentralized
More news about: American Institute Of Chemical Engineers
Sep 18, 2025, 09:10 ET Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics
27% growth rate[4]. Avant Technologies, Inc. (OTCQB: AVAI) has executed a strategic pivot into the high-growth longevity biotechnology sector through a transformative joint venture with Singapore-based Austrianova (SGAustria Pte. Ltd.), establishing
More news about: USA News Group
Sep 18, 2025, 09:00 ET Yoé Skincare, Known for Outperforming Beyond the Surface, Launches at Bloomingdale's
autoimmune-related skin sensitivity. When existing products failed to deliver results without irritation, Guo set out to create formulas rooted in biotechnology, skincare that delivers visible transformation by working beyond the surface. Yoé's hero products, the Ympossible Cream
More news about: Yoé & Co
Sep 18, 2025, 08:45 ET Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
between 2025 and 2034. The growth of the cell therapy market is driven by the increase in investments in research and development and advancements in biotechnology. Healthcare companies active in the markets this week include: Avant Technologies Inc. (OTCQB: AVAI), Tempus AI, Inc. (NASDAQ: TEM),
More news about: MarketNewsUpdates
Sep 18, 2025, 08:45 ET Nektar Presents New Data from REZOLVE-AD Phase 2b Study for Rezpegaldesleukin in Late-Breaker Oral Presentation at EADV 2025
the skin, leading to an immune reaction and inflammation. About Nektar Therapeutics Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases.
More news about: Nektar Therapeutics
Sep 18, 2025, 08:30 ET Avant Technologies and Austrianova Sign Joint Venture, Licensing Agreement to Advance Klotho-Based Therapies
Nevada-based corporation, and Austrianova (SGAustria Pte. Ltd.), a Singapore-based biotechnology leader, today announced the formation of a Joint Venture and License Agreement to establish Klothonova, Inc., a new Nevada
More news about: Avant Technologies Inc.
Sep 18, 2025, 08:30 ET Advancing Small Molecule Drug Discovery - New Developments in DEL Technology, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 18, 2025, 07:00 ET K36 Therapeutics to Present New Preclinical Data Supporting Ongoing Phase 1 Clinical Trial of KTX-1001 at the 22nd Annual International Myeloma Society Meeting
Sept. 18, 2025 /PRNewswire/ -- K36 Therapeutics, Inc. ("K36"), a privately held clinical-stage biotechnology company developing novel, targeted therapies for cancers with unmet medical need, today announced the presentation of two posters at the 22nd
More news about: K36 Therapeutics
Sep 18, 2025, 07:00 ET Marengo Therapeutics Advances STARt-002 Clinical Trial into Phase 2 Cohort Expansion Evaluating Invikafusp Alfa with TROP2-directed ADC TRODELVY® in Metastatic Breast Cancer
Sept. 18, 2025 /PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in oncology, inflammation and immunology (I&I), today announced the completion
More news about: Marengo Therapeutics
Sep 18, 2025, 06:55 ET Heat Transfer Fluids Market worth $6.3 billion by 2030 - Exclusive Report by MarketsandMarkets™
temperature-sensitive products, has significantly contributed to this segment's expansion. Additionally, the adoption of advanced technologies in biotechnology, semiconductor manufacturing, and electronics testing has increased the need for HTFs that perform efficiently without crystallization or loss of
More news about: MarketsandMarkets
Sep 18, 2025, 06:30 ET Flagship Pioneering Unveils Extuitive to Revolutionize Consumer Product Innovation and Creative Marketing Using Next-Gen AI
Sana Biotechnology,
More news about: Flagship Pioneering
Sep 18, 2025, 06:00 ET PlantArcBio Secures U.S. and South Korea Patents for DIPPER™ Platform, Advancing Gene-Editing Optimization in Crops
The DIPPER™ platform represents a significant advancement in plant biotechnology, enabling researchers and breeders to enhance the efficiency and precision of processes using gene-editing tools such as CRISPR to improve crop
More news about: PlantArcBio
Sep 17, 2025, 21:00 ET Results of China Phase III Clinical Study of Telitacicept for Generalized Myasthenia Gravis Selected for Oral Presentation at 2025 AANEM Annual Meeting
myasthenia gravis (gMG). About Vor Bio Vor Bio is a clinical-stage biotechnology company committed to the treatment of autoimmune diseases. The company focuses on rapidly advancing the Phase III clinical development and commercialization
More news about: RemeGen Co., Ltd
Sep 17, 2025, 19:30 ET Ascletis Presented Phase III Study Results of First-in-Class FASN Inhibitor Denifanstat (ASC40) for Acne Treatment in the Late Breaking News Sessions of the European Academy of Dermatology and Venereology (EADV) Congress 2025
rights in Greater China. About Ascletis Pharma Inc. Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases.
More news about: Ascletis Pharma Inc.
Sep 17, 2025, 18:01 ET Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Sep 17, 2025, 17:09 ET MagicRNA's First-in-Human Clinical Data Demonstrating Feasibility of In Vivo CAR T Therapy in Systemic Lupus Erythematosus Published in The New England Journal of Medicine.
China, Sept. 17, 2025 /PRNewswire/ -- MagicRNA, a clinical-stage biotechnology company pioneering in vivo CAR T-cell therapies, today announced the publication of the world's first clinical data of an mRNA-lipid nanoparticle
More news about: Shenzhen MagicRNA Biotech Co., Ltd.
Sep 17, 2025, 14:47 ET Thryv Therapeutics Announces FDA IND Clearance of THRV-1268 for Long QT Syndrome
MONTREAL, Sept. 17, 2025 /PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company pioneering novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for cardiovascular diseases, today announced that the U.S. Food
More news about: Thryv Therapeutics Inc.